Diabetes mellitus e sua relação com a COVID-19: um panorama atual proveniente de uma revisão sistemática

Bianca Sampaio  Lima; Maiza Carneiro Machado  Frota; Sara Prado  Ramos; José Lopes  Pereira Júnior; Antonio de Pádua Rocha  Nóbrega Neto

doi:10.33448/rsd-v10i15.22598

Autores/as

Bianca Sampaio Lima Instituto de Educação Superior do Vale do Parnaíba https://orcid.org/0000-0002-0574-4936
Maiza Carneiro Machado Frota Instituto de Educação Superior do Vale do Parnaíba https://orcid.org/0000-0002-3666-2749
Sara Prado Ramos Instituto de Educação Superior do Vale do Parnaíba https://orcid.org/0000-0001-8736-4621
José Lopes Pereira Júnior Instituto de Educação Superior do Vale do Parnaíba https://orcid.org/0000-0001-5621-7469
Antonio de Pádua Rocha Nóbrega Neto Instituto de Educação Superior do Vale do Parnaíba https://orcid.org/0000-0003-4829-0062

DOI:

https://doi.org/10.33448/rsd-v10i15.22598

Palabras clave:

Diabetes mellitus; COVID-19; Comorbilidad.

Resumen

Introducción: En la actualidad, la ocurrencia de Diabetes Mellitus tipo 2 (DM2) ha ido aumentando paulatinamente, lo que se convierte en una preocupación mundial. Esta preocupación se debe al hecho de que algunos estudios sugieren que la diabetes está asociada con un mayor riesgo de desarrollar formas graves de COVID-19. Objetivo: Realizar una revisión sistemática de la DM y su relación con COVID-19. Metodología: Se trata de un estudio de revisión sistemática de la literatura utilizando las bases de datos PubMed (Biblioteca Nacional de Medicina de los Estados Unidos) y Science Direct con los descriptores “Diabetes mellitus”, “covid-19”, “factores de riesgo / Diabetes mellitus”, “covid-19”, “comorbilidad”. La búsqueda fue limitada según la fecha de publicación (tiempo de 5 años: 2016-2021), especies (humanos), idiomas disponibles (inglés, español y portugués). Los artículos que no formaban parte del tema COVID-19 x Diabetes Mellitus fueron excluidos de la investigación. Resultados y Discusión: Durante el estudio se pudo observar la fuerte correlación entre el mal pronóstico de COVID-19 y Diabetes tipo 1 y 2 dado que la diabetes inmunodeprime el cuerpo humano, se entiende que una infección secundaria a COVID-19 es más persistente y letal. Conclusión: Se concluye que los pacientes con diabetes que contraen covid tienen peor pronóstico en comparación con los pacientes no diabéticos. Estos pacientes deben recibir una mayor atención por parte del sistema de salud, recibiendo medidas preventivas como un estricto control glucémico. También es urgente mostrar a esta población la importancia de la vacunación.

Citas

Abbas, H. M., Nassir, K. F., Al Khames Aga, Q. A., Al‐Gharawi, A. A., Rasheed, J. I., AL‐Obaidy, M. W., & Al Khames Aga, L. A. (2021). Presenting the characteristics, smoking versus diabetes, and outcome among patients hospitalized with COVID‐19. Journal of medical virology, 93(3), 1556-1567.

Akter, F., Mannan, A., Mehedi, H. H., Rob, M. A., Ahmed, S., Salauddin, A., & Hasan, M. M. (2020). Clinical characteristics and short term outcomes after recovery from COVID-19 in patients with and without diabetes in Bangladesh. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14(6), 2031-2038.

Akbariqomi, M., Hosseini, M. S., Rashidiani, J., Sedighian, H., Biganeh, H., Heidari, R., & Kooshki, H. (2020). Clinical characteristics and outcome of hospitalized COVID-19 patients with diabetes: A single-center, retrospective study in Iran. diabetes research and clinical practice, 169, 108467.

Alam, M. R., Kabir, M. R., & Reza, S. (2021). Comorbidities might be a risk factor for the incidence of COVID-19: Evidence from a web- based survey. Preventive Medicine Reports, 21, 101319.

Al‐Salameh, A., Lanoix, J. P., Bennis, Y., Andrejak, C., Brochot, E., Deschasse, G., & Lalau, J. D. (2021). Characteristics and outcomes of COVID‐19 in hospitalized patients with and without diabetes. Diabetes/metabolism research and reviews, 37(3), e3388.

Alzaid, F., Julla, J. B., Diedisheim, M., Potier, C., Potier, L., Velho, G., & Gautier, J. F. (2020). Monocytopenia, monocyte morphological anomalies and hyperinflammation characterise severe COVID‐19 in type 2 diabetes. EMBO molecular medicine, 12(10), e13038.

Arango-Guerra, P., Moncayo-Viveros, J. G., Correa-Londoño, N., García-Roncallo, A., Ramírez-Escobar, L., Sánchez-Moreno, A. M., & Moreno-Bedoya, S. (2021). Crisis hiperglucémica concomitante con infección por SARS-CoV-2: una serie de casos. Acta Colombiana de Cuidado Intensivo.

Barron, E., Bakhai, C., Kar, P., Weaver, A., Bradley, D., Ismail, H., & Valabhji, J. (2020). Associations of type 1 and type 2 diabetes with COVID-19- related mortality in England: a whole-population study. The lancet Diabetes & endocrinology, 8(10), 813-822.

Bhatti, R., Khamis, A. H., Khatib, S., Shiraz, S., & Matfin, G. (2020). Clinical Characteristics and Outcomes of Patients With Diabetes Admitted for COVID- 19 Treatment in Dubai: Single-Centre Cross-Sectional Study. JMIR public health and surveillance, 6(4), e22471.

Chan, K. H., Thimmareddygari, D., Ramahi, A., Atallah, L., Baranetsky, N. G., & Slim, J. (2020). Clinical characteristics and outcome in patients with combined diabetic ketoacidosis and hyperosmolar hyperglycemic state associated with COVID- 19: a retrospective, hospital-based observational case series. Diabetes research and clinical practice, 166, 108279.

Chen, Q., Zheng, Z., Zhang, C., Zhang, X., Wu, H., Wang, J., & Zheng, C. (2020). Clinical characteristics of 145 patients with corona virus disease 2019 (COVID-19) in Taizhou, Zhejiang, China. Infection, 48(4), 543-551.

Cheng, Y., Yue, L., Wang, Z., Zhang, J., & Xiang, G. (2021). Hyperglycemia associated with lymphopenia and disease severity of COVID-19 in type 2 diabetes mellitus. Journal of Diabetes and its Complications, 35(2), 107809.

Dyusupova, A., Faizova, R., Yurkovskaya, O., Belyaeva, T., Terekhova, T., Khismetova, A., & Glushkova, N. (2021). Clinical characteristics and risk factors for disease severity and mortality of COVID-19 patients with diabetes mellitus in Kazakhstan: A nationwide study. Heliyon, 7(3), e06561.

Ebinger, J. E., Achamallah, N., Ji, H., Claggett, B. L., Sun, N., Botting, P., & Cheng, S. (2020). Pre-existing traits associated with Covid- 19 illness severity. PloS one, 15(7), e0236240.

Escobedo-de la Peña, J., Pacheco, R. A. R., de Jesús Ascencio-Montiel, I., González-Figueroa, E., Fernández-Gárate, J. E., Medina-Gómez, O. S., & Borja- Aburto, V. H. (2020). Hypertension, diabetes and obesity, major risk factors for death in patients with COVID-19 in Mexico. Archives of Medical Research.

Fadini, G. P., Morieri, M. L., Boscari, F., Fioretto, P., Maran, A., Busetto, L., & Vettor, R. (2020). Newly- diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration. Diabetes research and clinical practice, 168, 108374.

Fox, T., Ruddiman, K., Lo, K. B., Peterson, E., DeJoy, R., Salacup, G., & Patarroyo-Aponte, G. (2021). The relationship between diabetes and clinical outcomes in COVID-19: a single-center retrospective analysis. Acta Diabetologica, 58(1), 33-38.

Kim, M. K., Jeon, J. H., Kim, S. W., Moon, J. S., Cho, N. H., Han, E., & Lee, J. H. (2020). The clinical characteristics and outcomes of patients with moderate- to-severe coronavirus disease 2019 infection and diabetes in Daegu, South Korea. Diabetes & metabolism journal, 44(4), 602.

Lampasona, V., Secchi, M., Scavini, M., Bazzigaluppi, E., Brigatti, C., Marzinotto, I., & Piemonti, L. (2020). Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study. Diabetologia, 63(12), 2548-2558.

Liang, J. J., Liu, J., Chen, Y., Ye, B., Li, N., Wang, X., & Shao, J. (2020). Characteristics of laboratory findings of COVID-19 patients with comorbid diabetes mellitus. Diabetes research and clinical practice, 167, 108351.

Liu, Y., Lu, R., Wang, J., Cheng, Q., Zhang, R., Zhang, S., & Hong, T. (2021). Diabetes, even newly defined by HbA1c testing, is associated with an increased risk of in-hospital death in adults with COVID- 19. BMC Endocrine Disorders, 21(1), 1-10.

Liu, Z., Li, J., Huang, J., Guo, L., Gao, R., Luo, K., & Wu, X. (2020). Association Between Diabetes and COVID-19: A Retrospective Observational Study With a Large Sample of 1,880 Cases in Leishenshan Hospital, Wuhan. Frontiers in endocrinology, 11, 478.

McGurnaghan, S. J., Weir, A., Bishop, J., Kennedy, S., Blackbourn, L. A., McAllister, D. A., & Health Protection Study Group. (2021). Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland. The Lancet Diabetes & Endocrinology, 9(2), 82-93.

Mishra, Y., Pathak, B. K., Mohakuda, S. S., Tilak, T. V. S. V. G. K., Sen, S., Harikrishnan, P., & Singh, A. R. (2020). Relation of D-dimer levels of COVID- 19 patients with diabetes mellitus. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14(6), 1927-1930.

Mithal, A., Jevalikar, G., Sharma, R., Singh, A., Farooqui, K. J., Mahendru, S., & Budhiraja, S. (2021). High prevalence of diabetes and other comorbidities in hospitalized patients with COVID-19 in Delhi, India, and their association with outcomes. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 15(1), 169-175.

Mondal, S., DasGupta, R., Lodh, M., Gorai, R., Choudhury, B., Hazra, A. K., & Ganguly, A. (2021). Predictors of new- onset diabetic ketoacidosis in patients with moderate to severe COVID-19 receiving parenteral glucocorticoids: A prospective single- centre study among Indian type 2 diabetes patients. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 15(3), 795-801.

Odriozola, A., Ortega, L., Martinez, L., Odriozola, S., Torrens, A., Corroleu, D., & Malik, R. A. (2021). Widespread sensory neuropathy in diabetic patients hospitalized with severe COVID-19 infection. Diabetes research and clinical practice, 172, 108631.

O’Malley, G., Ebekozien, O., Desimone, M., Pinnaro, C. T., Roberts, A., Polsky, S., & Levy, C. J. (2021). COVID-19 Hospitalization in Adults with Type 1 Diabetes: Results from the T1D Exchange Multicenter Surveillance Study. The Journal of Clinical Endocrinology & Metabolism, 106(2), e936-e942.

Satman, I., Demirci, I., Haymana, C., Tasci, I., Salman, S., Ata, N., & Sonmez, A. (2021). Unexpectedly lower mortality rates in COVID- 19 patients with and without type 2 diabetes in Istanbul. Diabetes Research and Clinical Practice, 174, 108753.

Schlömmer, C., Dünser, M. W., Antlanger, M., Paar, C., Winkler, M., Meier, J., & Salzer, H. J. (2020). Fatal case of COVID-19 in a 27-year- old woman with diabetes mellitus. Wiener klinische Wochenschrift, 132(21), 695-696.

Shang, J., Wang, Q., Zhang, H., Wang, X., Wan, J., Yan, Y., & Lin, J. (2021). The relationship between diabetes mellitus and COVID-19 prognosis: a retrospective cohort study in Wuhan, China. The American journal of medicine, 134(1), e6-e14.

Sun, Y., Guan, X., Jia, L., Xing, N., Cheng, L., Liu, B., & He, K. (2021). Independent and combined effects of hypertension and diabetes on clinical outcomes in patients with COVID‐19: A retrospective cohort study of Huoshen Mountain Hospital and Guanggu Fangcang Shelter Hospital. The Journal of Clinical Hypertension, 23(2), 218-231.

Ushigome, E., Yamazaki, M., Hamaguchi, M., Ito, T., Matsubara, S., Tsuchido, Y., & Fukui, M. (2021). Usefulness and safety of remote continuous glucose monitoring for a severe COVID-19 patient with diabetes. DiabetesTechnology & Therapeutics, 23(1), 78-80.

Yan, Y., Yang, Y., Wang, F., Ren, H., Zhang, S., Shi, X., & Dong, K. (2020). Clinical characteristics and outcomes of patients with severe covid- 19 with diabetes. BMJ open diabetes research and care, 8(1), e001343.

Zhang, N., Wang, C., Zhu, F., Mao, H., Bai, P., Chen, L. L., & Zhou, M. (2020). Risk factors for poor outcomes of diabetes patients with COVID-19: a single- center, retrospective study in early outbreak in China. Frontiers in endocrinology, 11.

Zhang, Q., Wei, Y., Chen, M., Wan, Q., & Chen, X. (2020). Clinical analysis of risk factors for severe COVID-19 patients with type 2 diabetes. Journal of Diabetes and its Complications, 34(10)

Diabetes mellitus y su relación con COVID-19: resumen actual de una revisión sistemática

Autores/as

DOI:

Palabras clave:

Resumen

Citas

Descargas

Publicado

Cómo citar

Número

Sección

Licencia

JOURNAL METRICS

Idioma

Enviar un artículo